2023
DOI: 10.1016/j.htct.2022.08.008
|View full text |Cite
|
Sign up to set email alerts
|

To study the effect of ‘Covishield’ vaccination on pre-donation platelet counts of plateletpheresis donors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…Recombinant adenoviral vectors have been documented to cause thrombocytopenia in vivo as well (114,115). In fact, a study by one of the largest government-owned transfusion centers in India showed significant deferral rates for plateletpheresis donors who had received one or two doses of ChAdOx1 nCoV-19 due to significantly lower platelet counts compared to controls (116). A study by Nicolai et al showed that IV, but not IM delivery of ChAdOx1 nCov-19 into mice led to thrombocytopenia (117).…”
Section: Adenovirus Vector As a Potential Polyanionmentioning
confidence: 99%
“…Recombinant adenoviral vectors have been documented to cause thrombocytopenia in vivo as well (114,115). In fact, a study by one of the largest government-owned transfusion centers in India showed significant deferral rates for plateletpheresis donors who had received one or two doses of ChAdOx1 nCoV-19 due to significantly lower platelet counts compared to controls (116). A study by Nicolai et al showed that IV, but not IM delivery of ChAdOx1 nCov-19 into mice led to thrombocytopenia (117).…”
Section: Adenovirus Vector As a Potential Polyanionmentioning
confidence: 99%